Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021
Opiant Pharmaceuticals (NASDAQ: OPNT) will report its third quarter 2021 financial results and pipeline updates on November 11, 2021, after U.S. market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals (NASDAQ: OPNT) will report its third quarter 2021 financial results and pipeline updates on November 11, 2021, after U.S. market close. A conference call is scheduled for 4:30 p.m. ET on the same day to discuss the results and operational progress. Investors can access the call via phone or a live webcast through the company's website. Opiant is known for its development of NARCAN® Nasal Spray and is focusing on expanding its portfolio to address addictions and drug overdoses.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was -4.82%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report third quarter 2021 financial results and pipeline updates on Thursday, November 11, 2021, after U.S. financial markets close.
The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, November 11, 2021 to discuss the results and operational progress.
To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13723604. To access the live webcast, please visit http://public.viavid.com/index.php?id=146696. Following the live webcast, an archived version of the call will be available on the website.
Thursday November 11 @ 4:30 pm ET
| Domestic: | 877-407-0792 |
| International: | 201-689-8263 |
| Conference ID: | 13723604 |
| Webcast: | http://public.viavid.com/index.php?id=146696 |
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.